Document is current
Any future updates will be listed below
-
Authors
Guo, Jhe-Cyuan https://orcid.org/0000-0002-6689-9640
Lin, Chia-Chi
Hsu, Chia-Lang
Huang, Ta-Chen
Kuo, Hung-Yang
Lin, Chen-Yuan
Lien, Ming-Yu
Cheng, Ann-Lii
Hsu, Chih-Hung https://orcid.org/0000-0003-0495-973X
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 105-2314-B-002-186-MY3)
Ministry of Science and Technology, Taiwan (MOST 108-2314-B-002-076-MY3)
Ministry of Science and Technology, Taiwan (MOST-106-2314-B-002-225-MY2)
Ministry of Science and Technology, Taiwan (MOST 108-3017-F-002-004-)
Ministry of Science and Technology, Taiwan (MOST 106-2314-B-002-135-)
Ministry of Science and Technology, Taiwan (MOST 107-2314-B-002-199-)
Ministry of Science and Technology, Taiwan (MOST 108-2314-B-002-096-)
Ministry of Science and Technology, Taiwan (MOST 109-2314-B-002-231-)
Ministry of Health and Welfare (MOHW 107-TDU-B-211-114017)
Ministry of Health and Welfare (MOHW111-TDU-B-221-114006)
National Taiwan University Hospital (NTUH 106-N3695)
National Taiwan University Cancer Center (NTUCCS-109-02)
National Taiwan University Cancer Center (NTUCCS-110-10)
National Taiwan University Cancer Center (NTUCC-111-05)
National Health Research Institutes (NHRI-107A1-CACO-01181816)
National Health Research Institutes (NHRI-108A1-CACO-01191916)
National Taiwan University (NTU-108L901403)
- License Information
-
More Information
Article History
Received: 6 April 2022
Accepted: 19 June 2022
First Online: 11 July 2022
Declarations
:
: Chih-Hung Hsu reports grants from Ministry of Science and Technology, ROC, grants from Ministry of Health and Welfare, ROC, during the conduct of the study; grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Merck Sharp and Dohme (MSD), grants and personal fees from Roche, personal fees from Merck Serono, grants from Beigene, grants from AstraZeneca, outside the submitted work. Jhe-Cyuan Guo reports grants from Ministry of Science and Technology, ROC, grants from National Taiwan University Hospital, grants from National Taiwan University Cancer Center, during the conduct of the study; personal fees from Bristol-Myers Squibb, personal fees from Ono Pharmaceutical, personal fees from Merck Sharp and Dohme (MSD) outside the submitted work. Chen-Yuan Lin and Ming-Yu Lien report personal fees from Bristol-Myers Squibb, personal fees from Ono Pharmaceutical, outside the submitted work. All other authors declare no conflicts of interest.
: This study protocol was approved by the Research Ethics Committee of National Taiwan University Hospital (approval No. 201612155RINB).
